DUSA Pharmaceuticals Inc. (DUSA) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.16 --0%
Financial Fact:
DILUTED NET INCOME (LOSS) PER COMMON SHARE: -0.06
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
DILUTED NET INCOME (LOSS) PER COMMON SHARE: -0.06
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
DUSA Pharmaceuticals Inc. (NASDAQ: DUSA) reported Q1 EPS of $0.07, $0.06 better than the analyst estimate of $0.01. Revenue for the quarter came in at $11.1 million versus the consensus estimate of $9.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
